MECP2 and beyond: Phenotype-genotype correlations in Rett syndrome

Journal of Child Neurology

Volumn 18, Issue 10, 2003, Pages 669-674

  Christodoulou, John ^a,b   Weaving, Linda S ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ARTICLE; DNA MICROARRAY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HAPPY PUPPET SYNDROME; HUMAN; MEDICAL RESEARCH; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER;

EID: 0242539772     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180100901     Document Type: Article

References (75)

1. Leonard H, Bower C, English D: The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997;6(Suppl):S8-S10.
2. Hagberg B, Goutiéres F, Hanefield F, et al: Rett syndrome: Criteria for inclusion and exclusion. Brain Dev 1985;7:372-373.
3. Ellaway CJ, Williams K, Leonard H, et al: Rett syndrome: Randomised controlled trial of L-carnitine. J Child Neurol 1999; 14:162-167.
4. Trevathan E, Moser HW (Rett Syndrome Working Group): Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-428.
5. Goutiéres F, Aicardi J: New experience with Rett syndrome in France: The problem of atypical cases. Brain Dev 1987;9:502-505.
6. Hagberg B, Witt-Engerstrom I: Rett syndrome: Epidemiology and nosology - Progress in knowledge 1986A conference communication. Brain Dev 1987;9:451-457.
7. Percy AK, Zoghbi HY, Glaze DG: Rett syndrome: Discrimination of typical and variant forms. Brain Dev 1987;9:458-461.
8. Hagberg BA, Skjeldal OH: Rett variants: A suggested model for inclusion criteria. Pediatr Neurol 1994;11:5-11.
9. Zappella M: The Rett girls with preserved speech. Brain Dev 1992;14:98-101.
10. Naidu S, Bibat G, Kratz L, et al: Clinical variability in Rett syndrome. J Child Neurol 2003;18:662-668.
11. Hagberg B, Aicardi J, Dias K, et al: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471-479.
12. Armstrong DD: Review of Rett syndrome. J Neuropathol Exp Neurol 1997;56:843-849.
13. Ellaway CJ, Peat J, Williams K, et al: Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev 2001;23(Suppl 1): S85-S89.
14. Percy AK: Clinical trials and treatment prospects. Mental Retard Dev Disabil Res Rev 2002;8:106-111.
15. Journel H, Melki J, Turleau C, et al: Rett phenotype with X/auto-some translocation: Possible mapping to the short arm of chromosome X. Am J Med Genet 1990;35:142-147.
16. Zoghbi HY, Ledbetter DH, Schultz R, et al: A de novo X;3 translocation in Rett syndrome. Am J Med Genet 1990;35:148-151.
17. Delobel B, Delannoy V, Pini G, et al: Identification and molecular characterisation of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations. Am J Med Genet 1998;80: 273-280.
18. Gustavsson P, Kimber E, Wahlstrom J, et al: Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 1999;82:348-351.
19. Wahström J, Uller A, Johannesson T, et al: Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet 1999;36:343-345.
20. Tang J, Qi Y, Bao XH, et al: Mutational analysis of mitochondrial DNA of children with Rett syndrome. Pediatr Neurol 1997; 17:327-330.
21. Ellaway CJ, McQuade LR, Christodoulou J: Novel mitochondrial 16S rRNA polymorphism in a girl with Rett syndrome. J Inherit Metab Dis 1999;22:946-947.
22. Ellison KA, Fill CP, Terwilliger J, et al: Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet 1992;50:278-287.
23. Curtis A, Headland S, Lindsay S, et al: X chromosome linkage studies in familial Rett syndrome. Hum Genet 1993;90:551-555.
24. Schanen NC, Dahle EJ, Capozzoli F, et al: A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 1997;61:634-641.
25. Schanen C, Francke U: A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet 1998;63:267-269.
26. Sirianni N, Naidu S, Pereira J, et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localisation of the gone to Xq28 [letter]. Am J Hum Genet 1998;63:1552-1558.
27. Amir RE, van den Veyver IB, Wan M, et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
28. Nan X, Meehan RR, Bird A: Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acid Res 1993;21:4886-4892.
29. Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997; 88:471-481.
30. Jones PL, Veenstra GJC, Wade PA, et al: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187-191.
31. Nan X, Ng H-H, Johnson CA, et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-389.
32. Kokura K, Kaul SC, Wadhwa R, et al: The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 2001;276:34115-34121.
33. Yu F, Thiesen J, Strätling WH: Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acid Res 2001;28:2201-2206.
34. Hoffbuhr KC, Moses LM, Jerdonek MA, et al: Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Mental Retard Dev Disabil Res Rev 2002;8:99-105.
35. Christodoulou J, Grimm A, Maher T, et al: RettBASE: The IRSA MECP2 Variation Database. A new mutation database in evolution. Hum Mut 2003;31(6):466-472.
36. Nielsen JB, Henriksen KF, Hansen C, et al: MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 2001;9:178-184.
37. Bourdon V, Philippe C, Labrune O, et al: A detailed analysis of the MECP2 gene: Prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 2001;108:43-50.
38. Wan MM, Lee SSJ, Zhang XY, et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999;65:1520-1529.
39. Thomas GH: High male:female ratio of germ-line mutations: An alternative explanation for postulated gestational lethality in males with X-linked dominant disorders. Am J Hum Genet 1996;58:1364-1368.
40. Girard M, Couvert P Carrié A, et al: Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 2001; 9:231-236.
41. Trappe R, Laccone F, Cobilanschi J, et al: MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001;68:1093-1101.
42. Meehan RR, Lewis JD, McKay S, et al: Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989;58:499-507.
43. Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localisation of a novel chromosomal protein that binds to methylated DNA. Cell 1992;69:905-914.
44. Nan X, Cross S, Bird A. Gene silencing by methyl-CpG-binding proteins. Epigenetics. Novartis Foundation Symposium, vol 214. Wiley, Chichester, UK, 1998, 6-21.
45. Goutiéres F, Aicardi J. Atypical forms of Rett syndrome. Am J Med Genet 1986;24 (Suppl 1):183-194.
46. Skjeldal OH, von Tetzchner S, Jacobsen K, et al: Rett syndrome -Distribution of phenotypes with special attention to the preserved speech variant. Neuropediatrics 1995;26:87.
47. Weaving LS, Williamson SL, Bennetts B, et al: Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet 2003;118A:103-114.
48. Cheadle JP, Gill H, Fleming N, et al: Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location. Hum Mol Genet 2000;9:1119-1129.
49. Huppke P, Laccone F, Kramer N, et al: Rett syndrome: Analysis of MECP2 and clinical characterisation of 31 patients. Hum Mol Genet 2000;9:1369-1375.
50. Hoffbuhr K, Devaney JM, LaFleur B, et al: MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 2001;56:1486-1495.
51. Zoghbi HY, Percy AK, Schultz RJ, et al: Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 1990;12:131-135.
52. Bienvenu T, Carrié A, De Roux N, et al: MECP2 mutations account for most cases of typical form as of Rett syndrome. Hum Mol Genet 2000;9:1377-1384.
53. Amir RE, Van den Veyver IB, Schultz R, et al: Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 2000;47:670-679.
54. Ishii T, Makita Y, Ogawa A, et al: The role of different X-inactivation patterns on the variable clinical phenotype with Rett syndrome. Brain Dev 2001;23(Suppl 1):S161-S164.
55. van den Veyver IB, Zoghbi HY: Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr Opin Genet Dev 2000;10: 275-279.
56. Schwartzman JS, Bernardino A, Nishimura A, et al: Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 2001;32:162-164.
57. Villard L, Kpebe A, Cardoso C, et al: Two affected boys in a Rett syndrome family - Clinical and molecular findings. Neurology 2000;55:1188-1193.
58. Clayton-Smith J, Watson P, Ramsden S, et al: Somatic mutation in MECP2 as a nonfatal neurodevelopmental disorder in males. Lancet 2000;356:830-832.
59. Orrico A, Lam C-W, Galli L, et al: MECP2 mutation in male patients with nonspecific X-linked mental retardation. FEBS Lett 2000;481:285-288.
60. Yntema HG, Kleefstra T, Oudakker AR, et al: Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 2002;10:487-490.
61. Meloni I, Bruttini M, Longo I, et al: A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000;67:982-985.
62. Klauck SM, Lindsay S, Beyer KS, et al: A mutation hot spot for non-specific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002;70:1034-1037.
63. Watson P, Black G, Ramsden S, et al: Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 2001;38:224-228.
64. Vourc'h P, Bienvenu T, Beldjord C, et al: No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. Eur J Hum Genet 2001;9:556-558.
65. Beyer KS, Blasi F, Bacchelli E, et al: Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002;111:305-309.
66. Lobo-Menendez F, Sossey-Alaoui K, Bell JM, et al: Absence of MECP2 mutations in patients from the South Carolina autism project. Am J Med Genet 2003;11713:97-101.
67. Laccone F, Zoll B, Huppke P, et al: MECP2 gene nucleotide changes and their pathogenicity in males: Proceed with caution. J Med Genet 2002;39:586-588.
68. Imessaoudene B, Bonnefont JP, Royer G, et al: MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 2001;38:171-174.
69. Kudo S, Nomura Y, Segawa M, et al: Functional analyses of MECP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev 2001;23(Suppl 1):S165-S173.
70. Chen RZ, Akbarian S, Tudor M, et al: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001;27:327-331.
71. Guy J, Hendrich B, Holmes M, et al: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001;27:322-326.
72. Shahbazian M, Young J, Yuva-Paylor L, et al: Mice with truncated MeCP2 recapitulate many Red syndrome features and display hyperacetylation of histone H3. Neuron 2002;35:243-254.
73. Colantuoni C, Jeon OH, Hyder K, et al: Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification. Neurobiol Dis 2001;8:847-865.
74. Tudor M, Akbarian S, Chen RZ, et al: Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 2002;99: 15536-15541.
75. Vacca M, Filippini F, Budillon A, et al: Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J Mol Med 2001;78:648-655.